157 results on '"Jankowska, Ewa Anita"'
Search Results
2. Catabolic/Anabolic Imbalance Is Accompanied by Changes of Left Ventricular Steroid Nuclear Receptor Expression in Tachycardia-Induced Systolic Heart Failure in Male Pigs
3. Health-related quality of life and self-care in heart failure patients under telecare—insights from the randomized, prospective, controlled AMULET trial.
4. The Usefulness of the C 2 HEST Score in Predicting the Clinical Outcomes of COVID-19 in COPD and Non-COPD Cohorts.
5. Antiplatelet therapy prior to COVID-19 infection impacts on patients mortality: A propensity score-matched cohort study.
6. Association of serum vitamin D concentration with the final course of hospitalization in patients with COVID-19
7. Iron Status and Short-Term Recovery after Non-Severe Acute Myocarditis: A Prospective Observational Study
8. Dysnatremia in COVID-19 Patients—An Analysis of the COLOS Study
9. Cardiovascular Complications of Viral Respiratory Infections and COVID-19
10. Iron Deficiency and Deranged Myocardial Energetics in Heart Failure
11. Increased body fat is associated with potentiation of blood pressure response to hypoxia in healthy men: relations with insulin and leptin
12. Patterns of Locus of Control in People Suffering from Heart Failure: An Approach by Clustering Method
13. The Usefulness of the COVID-GRAM Score in Predicting the Outcomes of Study Population with COVID-19
14. Digital health and modern technologies applied in patients with heart failure: Can we support patients’ psychosocial well-being?
15. Distance covered during a six-minute walk test predicts long-term cardiovascular mortality and hospitalisation rates in men with systolic heart failure: an observational study
16. The Usefulness of the C2HEST Risk Score in Predicting Clinical Outcomes among Hospitalized Subjects with COVID-19 and Coronary Artery Disease
17. Liver Function Tests in COVID-19: Assessment of the Actual Prognostic Value
18. Usefulness of C2HEST Score in Predicting Clinical Outcomes of COVID-19 in Heart Failure and Non-Heart-Failure Cohorts
19. Assessment of Gastrointestinal Symptoms and Dyspnea in Patients Hospitalized due to COVID-19: Contribution to Clinical Course and Mortality
20. Sex-Dependent Differences in Predictive Value of the C2HEST Score in Subjects with COVID-19—A Secondary Analysis of the COLOS Study
21. Education and certification on heart failure of the Heart Failure Association of the European Society of Cardiology
22. Mortality Predictive Value of the C2HEST Score in Elderly Subjects with COVID-19—A Subanalysis of the COLOS Study
23. Cardiovascular Complications of Viral Respiratory Infections and COVID-19.
24. Differences in the Biomarker Profile of De Novo Acute Heart Failure versus Decompensation of Chronic Heart Failure
25. Nutritional and Non-Nutritional Predictors of Low Spot Urinary Creatinine Concentration in Patients with Heart Failure
26. Expert opinion of the Heart Failure Working Group of the Polish Cardiac Society on the use of dapagliflozin in the treatment of heart failure with reduced ejection fraction
27. Jak rozpoznawać niewydolność serca z zachowaną frakcją wyrzutową. Praktyczny przewodnik Klubu 30 Polskiego Towarzystwa Kardiologicznego
28. Patterns of dyspnoea onset in patients with acute heart failure: clinical and prognostic implications
29. The short-term benefit from nurse-led ambulatory care supported by non-invasive haemodynamic assessment in patients after acute heart failure decompensation depends on time since hospital discharge
30. Rationale and design of the AMULET study: A new Model of telemedical care in patients with heart failure
31. Nurse‐led ambulatory care supported by non‐invasive haemodynamic assessment after acute heart failure decompensation
32. Anaemia and iron deficiency in patients with rheumatoid arthritis and other chronic diseases*
33. Distinct clinical phenotypes of congestion in acute heart failure: characteristics, treatment response, and outcomes
34. The patient with heart failure in the face of the coronavirus disease 2019 pandemic: an expert opinion of the Heart Failure Working Group of the Polish Cardiac Society
35. Iron metabolism in patients with rheumatoid arthritis
36. Anaemia and iron deficiency in patients with rheumatoid arthritis and other chronic diseases*.
37. Social inequality in premature mortality among Polish urban adults during economic transition
38. Both iron excess and iron depletion impair viability of rat H9C2 cardiomyocytes and L6G8C5 myocytes
39. The short-term benefit from nurse-led ambulatory care supported by non-invasive haemodynamic assessment in patients after acute heart failure decompensation depends on the time since hospital discharge.
40. THE ASSOCIATION OF BLOOD TRIGLYCERIDE (TG) CONCENTRATION WITH THE COURSE OF HOSPITALIZATION IN PATIENTS WITH COVID-19.
41. Urinary levels of novel kidney biomarkers and risk of true worsening renal function and mortality in patients with acute heart failure
42. Iron deficiency in heart failure: Impact on response to cardiac resynchronization therapy
43. Patterns of dyspnoea onset in patients with acute heart failure: clinical and prognostic implications.
44. Late Cardiac Tamponade as a Result of Parietal Pericardium Erosion
45. Psychological aspects of heart failure – beyond depression, anxiety and quality of life
46. EFFECTS OF INTRAVENOUS IRON THERAPY IN IRON DEFICIENT PATIENTS WITH SYSTOLIC HEART FAILURE: META-ANALYSIS OF RANDOMIZED CONTROL TRIALS
47. Baroreceptor sensitivity and diabetes mellitus
48. Sleep disordered breathing in patients with heart failure
49. Intracardiac thrombi in pulmonary embolism of a priori non high risk: therapeutic dilemma
50. Application of levosimendan in acute heart failure patients with symptoms of low cardiac output: case series report
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.